{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:15:33Z","timestamp":1791065733606,"version":"4.1.0"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Invariant NKT (iNKT) cells are a subset of T lymphocytes that recognize glycolipid Ags presented by the MHC class I\u2013related protein CD1d. Activation of iNKT cells with glycolipid Ags, such as the marine sponge\u2013derived reagent \u03b1-galactosylceramide (\u03b1-GalCer), results in the rapid production of a variety of cytokines and activation of many other immune cell types. These immunomodulatory properties of iNKT cells have been exploited for the development of immunotherapies against a variety of autoimmune and inflammatory diseases, but mechanisms by which activated iNKT cells confer disease protection have remained incompletely understood. In this study, we demonstrate that glycolipid-activated iNKT cells cooperate with myeloid-derived suppressor cells (MDSCs) in protecting mice against the development of experimental autoimmune encephalomyelitis (EAE) in mice, an animal model for multiple sclerosis. We show that \u03b1-GalCer induced the expansion and immunosuppressive activities of MDSCs in the spleen of mice induced for development of EAE. Disease protection in these animals also correlated with recruitment of MDSCs to the CNS. Depletion of MDSCs abrogated the protective effects of \u03b1-GalCer against EAE and, conversely, adoptive transfer of MDSCs from \u03b1-GalCer-treated mice ameliorated passive EAE induced in recipient animals. The cytokines GM-CSF, IL-4, and IFN-\u03b3, produced by activated iNKT cells, and inducible NO synthase, arginase-1, and IL-10 produced by MDSCs, contributed to these effects. Our findings have revealed cooperative immunosuppressive interactions between iNKT cells and MDSCs that might be exploited for the development of improved immunotherapies for multiple sclerosis and other autoimmune and inflammatory diseases.<\/jats:p>","DOI":"10.4049\/jimmunol.1201718","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T10:49:01Z","timestamp":1359024541000},"page":"1948-1960","source":"Crossref","is-referenced-by-count":59,"title":["Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells"],"prefix":"10.1093","volume":"190","author":[{"given":"Vrajesh V","family":"Parekh","sequence":"first","affiliation":[{"name":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine , Nashville, TN 37232"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine , Nashville, TN 37232"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyvid","family":"Olivares-Villag\u00f3mez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine , Nashville, TN 37232"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith T","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine , Nashville, TN 37232"},{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University School of Medicine , Nashville, TN 37232"},{"name":"Veterans Affairs Tennessee Valley Healthcare System , Nashville, TN 37232"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Van Kaer","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine , Nashville, TN 37232"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,3,1]]},"reference":[{"key":"2025032406391242900_r1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"Bendelac","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"2025032406391242900_r2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.immunol.21.120601.141057","article-title":"The regulatory role of Valpha14 NKT cells in innate and acquired immune response","volume":"21","author":"Taniguchi","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"2025032406391242900_r3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1146\/annurev.immunol.23.021704.115742","article-title":"Toward an understanding of NKT cell biology: progress and paradoxes","volume":"23","author":"Kronenberg","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"2025032406391242900_r4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1146\/annurev.immunol.22.012703.104608","article-title":"CD1: antigen presentation and T cell function","volume":"22","author":"Brigl","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"2025032406391242900_r5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08830180601070179","article-title":"The in vivo response of invariant natural killer T cells to glycolipid antigens","volume":"26","author":"Parekh","year":"2007","journal-title":"Int. Rev. Immunol."},{"key":"2025032406391242900_r6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.coi.2008.03.018","article-title":"CD1d-restricted iNKT cells, the \u2018Swiss-Army knife\u2019 of the immune system","volume":"20","author":"Matsuda","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"2025032406391242900_r7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/imt.10.85","article-title":"Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens","volume":"3","author":"Van Kaer","year":"2011","journal-title":"Immunotherapy"},{"key":"2025032406391242900_r8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00441-010-1023-3","article-title":"Invariant natural killer T cells: bridging innate and adaptive immunity","volume":"343","author":"Van Kaer","year":"2011","journal-title":"Cell Tissue Res."},{"key":"2025032406391242900_r9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nri1531","article-title":"\u03b1-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles","volume":"5","author":"Van Kaer","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"2025032406391242900_r10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1028","article-title":"Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity","volume":"3","author":"Wilson","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"2025032406391242900_r11","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1172\/JCI24762","article-title":"Glycolipid antigen induces long-term natural killer T cell anergy in mice","volume":"115","author":"Parekh","year":"2005","journal-title":"J. Clin. Invest."},{"key":"2025032406391242900_r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2012.08.009","article-title":"Invariant natural killer T cells as sensors and managers of inflammation","volume-title":"Trends Immunol.","author":"Van Kaer","year":"2012"},{"key":"2025032406391242900_r13","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1084\/jem.194.12.1801","article-title":"Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis","volume":"194","author":"Singh","year":"2001","journal-title":"J. Exp. Med."},{"key":"2025032406391242900_r14","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.4049\/jimmunol.173.6.3693","article-title":"Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids","volume":"173","author":"Parekh","year":"2004","journal-title":"J. Immunol."},{"key":"2025032406391242900_r15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/35097097","article-title":"A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells","volume":"413","author":"Miyamoto","year":"2001","journal-title":"Nature"},{"key":"2025032406391242900_r16","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1084\/jem.194.12.1789","article-title":"Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis","volume":"194","author":"Jahng","year":"2001","journal-title":"J. Exp. Med."},{"key":"2025032406391242900_r17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4049\/jimmunol.166.1.662","article-title":"Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells","volume":"166","author":"P\u00e1l","year":"2001","journal-title":"J. Immunol."},{"key":"2025032406391242900_r18","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.200323885","article-title":"Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma","volume":"33","author":"Furlan","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"2025032406391242900_r19","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1073\/pnas.0809317106","article-title":"Invariant NKT cells inhibit development of the Th17 lineage","volume":"106","author":"Mars","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032406391242900_r20","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1189\/jlb.0708446","article-title":"Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4","volume":"85","author":"Bunt","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"2025032406391242900_r21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"2025032406391242900_r22","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J. Immunol."},{"key":"2025032406391242900_r23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by L-arginine metabolism","volume":"5","author":"Bronte","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"2025032406391242900_r24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10555-011-9268-1","article-title":"Myeloid cell diversification and complexity: an old concept with new turns in oncology","volume":"30","author":"Chioda","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"2025032406391242900_r25","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1002\/eji.200939892","article-title":"Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions","volume":"39","author":"Bronte","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"2025032406391242900_r26","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-08-1921","article-title":"Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes","volume":"69","author":"Rodriguez","year":"2009","journal-title":"Cancer Res."},{"key":"2025032406391242900_r27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1074-7613(00)80290-3","article-title":"CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4","volume":"6","author":"Mendiratta","year":"1997","journal-title":"Immunity"},{"key":"2025032406391242900_r28","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/nprot.2006.284","article-title":"Passive induction of experimental allergic encephalomyelitis","volume":"1","author":"Stromnes","year":"2006","journal-title":"Nat. Protoc."},{"key":"2025032406391242900_r29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","article-title":"Tumor-induced tolerance and immune suppression depend on the C\/EBPbeta transcription factor","volume":"32","author":"Marigo","year":"2010","journal-title":"Immunity"},{"key":"2025032406391242900_r30","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1158\/1078-0432.CCR-05-0883","article-title":"Gemcitabine selectively eliminates splenic Gr-1+\/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity","volume":"11","author":"Suzuki","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"2025032406391242900_r31","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.1158\/0008-5472.CAN-06-4639","article-title":"A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model","volume":"67","author":"Ko","year":"2007","journal-title":"Cancer Res."},{"key":"2025032406391242900_r32","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.4049\/jimmunol.179.8.5228","article-title":"CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis","volume":"179","author":"Zhu","year":"2007","journal-title":"J. Immunol."},{"key":"2025032406391242900_r33","doi-asserted-by":"crossref","first-page":"e15531","DOI":"10.1371\/journal.pone.0015531","article-title":"Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis","volume":"5","author":"Domingues","year":"2010","journal-title":"PLoS ONE"},{"key":"2025032406391242900_r34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","article-title":"Th1 and Th17 cells: adversaries and collaborators","volume":"1183","author":"Damsker","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2025032406391242900_r35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2011.02536.x","article-title":"Th17 cell, the new player of neuroinflammatory process in multiple sclerosis","volume":"74","author":"Jadidi-Niaragh","year":"2011","journal-title":"Scand. J. Immunol."},{"key":"2025032406391242900_r36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00281-009-0186-z","article-title":"Th17 cells in autoimmune demyelinating disease","volume":"32","author":"Segal","year":"2010","journal-title":"Semin. Immunopathol."},{"key":"2025032406391242900_r37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"162","author":"Fletcher","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"2025032406391242900_r38","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"2025032406391242900_r39","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coi.2010.01.021","article-title":"Myeloid-derived suppressor cell heterogeneity and subset definition","volume":"22","author":"Peranzoni","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"2025032406391242900_r40","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2999","article-title":"Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth","volume-title":"Nat. Med.","author":"Bruchard","year":"2012"},{"key":"2025032406391242900_r41","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4049\/jimmunol.1101816","article-title":"Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease","volume":"188","author":"Ioannou","year":"2012","journal-title":"J. Immunol."},{"key":"2025032406391242900_r42","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.4049\/jimmunol.1100403","article-title":"Plasticity of Ly-6C(hi) myeloid cells in T cell regulation","volume":"187","author":"Zhu","year":"2011","journal-title":"J. Immunol."},{"key":"2025032406391242900_r43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"2025032406391242900_r44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-2094-9-40","article-title":"Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice","volume":"9","author":"Guerrero","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"2025032406391242900_r45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"2025032406391242900_r46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jlb.65.2.217","article-title":"Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors","volume":"65","author":"Biermann","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"2025032406391242900_r47","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.immuni.2007.08.020","article-title":"Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development","volume":"27","author":"Griewank","year":"2007","journal-title":"Immunity"},{"key":"2025032406391242900_r48","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.4049\/jimmunol.175.6.3648","article-title":"Induction of regulatory properties in dendritic cells by Valpha14 NKT cells","volume":"175","author":"Kojo","year":"2005","journal-title":"J. Immunol."},{"key":"2025032406391242900_r49","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4049\/jimmunol.1103608","article-title":"Activation of invariant NKT cells in early phase of experimental autoimmune encephalomyelitis results in differentiation of Ly6Chi inflammatory monocyte to M2 macrophages and improved outcome","volume":"189","author":"Denney","year":"2012","journal-title":"J. Immunol."},{"key":"2025032406391242900_r50","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.intimp.2011.01.026","article-title":"MDSC in autoimmunity","volume":"11","author":"Cripps","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"2025032406391242900_r51","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1182\/blood-2008-07-168575","article-title":"Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease","volume":"113","author":"King","year":"2009","journal-title":"Blood"},{"key":"2025032406391242900_r52","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1182\/blood-2005-07-2804","article-title":"Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells","volume":"107","author":"Kotsianidis","year":"2006","journal-title":"Blood"},{"key":"2025032406391242900_r53","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1182\/blood-2012-01-404012","article-title":"CD1d expression on and regulation of murine hematopoietic stem and progenitor cells","volume":"119","author":"Broxmeyer","year":"2012","journal-title":"Blood"},{"key":"2025032406391242900_r54","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1521-4141(200207)32:7<1897::AID-IMMU1897>3.0.CO;2-Y","article-title":"Ligand-activated natural killer T lymphocytes promptly produce IL-3 and GM-CSF in vivo: relevance to peripheral myeloid recruitment","volume":"32","author":"Leite-de-Moraes","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"2025032406391242900_r55","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1172\/JCI28828","article-title":"Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells","volume":"116","author":"Gallina","year":"2006","journal-title":"J. Clin. Invest."},{"key":"2025032406391242900_r56","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1172\/JCI36264","article-title":"Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans","volume":"118","author":"De Santo","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2025032406391242900_r57","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4049\/jimmunol.0802430","article-title":"Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine","volume":"182","author":"Ko","year":"2009","journal-title":"J. Immunol."},{"key":"2025032406391242900_r58","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4049\/jimmunol.1100502","article-title":"Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouse","volume":"187","author":"Kmieciak","year":"2011","journal-title":"J. Immunol."},{"key":"2025032406391242900_r59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/cimm.1998.1445","article-title":"Induction of apoptosis in activated T cell blasts by suppressive macrophages: a possible immunotherapeutic approach for treatment of autoimmune disease","volume":"193","author":"McIntosh","year":"1999","journal-title":"Cell. Immunol."},{"key":"2025032406391242900_r60","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jaut.2008.08.006","article-title":"Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations","volume":"31","author":"Kerr","year":"2008","journal-title":"J. Autoimmun."},{"key":"2025032406391242900_r61","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/eji.201040569","article-title":"Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation","volume":"41","author":"Oh","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"2025032406391242900_r62","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.4049\/jimmunol.175.12.7898","article-title":"Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in the prevention of autoimmune myasthenia","volume":"175","author":"Liu","year":"2005","journal-title":"J. Immunol."},{"key":"2025032406391242900_r63","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.11489","article-title":"Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of alpha-galactosylceramide","volume":"50","author":"Chiba","year":"2004","journal-title":"Arthritis Rheum."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/190\/5\/1948\/61783035\/1201718.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/190\/5\/1948\/61783035\/1201718.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T03:38:11Z","timestamp":1742960291000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/190\/5\/1948\/8004235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,3,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1201718","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,3]]},"published":{"date-parts":[[2013,3,1]]}}}